Case Study

Overcoming Rare Disease Clinical Trials Challenges

Source: Kayentis
GettyImages-1088537588 disease

Over 90% of rare diseases have no treatment. There are more than 6,000 known rare diseases. Approximately 80% of them have a genetic component—75% affect children—and most rare diseases are chronic conditions, many of which progress over time and are potentially fatal.

Understanding the rare disease framework is key to being able to offer study participants adapted solutions and as such, positively contribute to important and necessary clinical research conducted on rare diseases.

  • What makes rare disease clinical trials so difficult?
  • How can we contribute to making this a smoother experience for the patients, their caregivers, and the clinical trials industry?

Find the answers in this case study.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader